{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:45:21Z","timestamp":1792759521314,"version":"4.5.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Patients taking high doses of opioids, or taking opioids in combination with other central nervous system depressants, are at increased risk of opioid overdose. Coprescribing the opioid-reversal agent naloxone is an essential safety measure, recommended by the surgeon general, but the rate of naloxone coprescribing is low. Therefore, we set out to determine whether a targeted clinical decision support alert could increase the rate of naloxone coprescribing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We conducted a before-after study from January 2019 to April 2021 at a large academic health system in the Southeast. We developed a targeted point of care decision support notification in the electronic health record to suggest ordering naloxone for patients who have a high risk of opioid overdose based on a high morphine equivalent daily dose (MEDD) \u226590 mg, concomitant benzodiazepine prescription, or a history of opioid use disorder or opioid overdose. We measured the rate of outpatient naloxone prescribing as our primary measure. A multivariable logistic regression model with robust variance to adjust for prescriptions within the same prescriber was implemented to estimate the association between alerts and naloxone coprescribing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      The baseline naloxone coprescribing rate in 2019 was 0.28 (95% confidence interval [CI], 0.24\u20130.31) naloxone prescriptions per 100 opioid prescriptions. After alert implementation, the naloxone coprescribing rate increased to 4.51 (95% CI, 4.33\u20134.68) naloxone prescriptions per 100 opioid prescriptions (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). The adjusted odds of naloxone coprescribing after alert implementation were approximately 28 times those during the baseline period (95% CI, 15\u201352).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>A targeted decision support alert for patients at risk for opioid overdose significantly increased the rate of naloxone coprescribing and was relatively easy to build.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000005976","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T11:08:03Z","timestamp":1648465683000},"page":"26-34","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["Assessment of a Naloxone Coprescribing Alert for Patients at Risk of Opioid Overdose: A Quality Improvement Project"],"prefix":"10.1213","volume":"135","author":[{"given":"Scott D.","family":"Nelson","sequence":"first","affiliation":[{"name":"Biomedical Informatics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison B.","family":"McCoy","sequence":"additional","affiliation":[{"name":"Biomedical Informatics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Rector","sequence":"additional","affiliation":[{"name":"Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Teare","sequence":"additional","affiliation":[{"name":"HealthIT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler W.","family":"Barrett","sequence":"additional","affiliation":[{"name":"Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Sigworth","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Edwards","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Division of Pain Medicine, Anesthesiology, and Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Marcovitz","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Wright","sequence":"additional","affiliation":[{"name":"Biomedical Informatics"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2105\/AJPH.2017.304265","article-title":"Quantifying the epidemic of prescription opioid overdose deaths.","volume":"108","author":"Seth","year":"2018","journal-title":"Am J Public Health"},{"key":"R2-20250502","first-page":"1","article-title":"Drugs most frequently involved in drug overdose deaths: United States, 2010-2014.","volume":"65","author":"Warner","year":"2016","journal-title":"Natl Vital Stat Rep"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2013.01.007","article-title":"Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers\u2014United States, 2002-2004 and 2008-2010.","volume":"132","author":"Jones","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"R4-20250502","first-page":"563","article-title":"Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines\u2014United States, 2012.","volume":"63","author":"Paulozzi","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/JAN.0000000000000230","article-title":"Naloxone effectiveness: a systematic review.","volume":"29","author":"Chimbar","year":"2018","journal-title":"J Addict Nurs"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/ADM.0000000000000034","article-title":"A systematic review of community opioid overdose prevention and naloxone distribution programs.","volume":"8","author":"Clark","year":"2014","journal-title":"J Addict Med"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2013United States, 2016.","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"R10-20250502","first-page":"215","article-title":"Using the electronic health record to combat the opioid crisis.","volume":"83","author":"Bonczek","year":"2019","journal-title":"Conn Med"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1016\/j.annemergmed.2018.08.370","article-title":"365 The effect of an electronic decision support tool on emergency department prescribing of naloxone.","volume":"72","author":"Kreshak","year":"2018","journal-title":"Ann Emerg Med"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/add.14635","article-title":"Do electronic health record prompts increase take-home naloxone administration for emergency department patients after an opioid overdose?","volume":"114","author":"Marino","year":"2019","journal-title":"Addiction"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2105\/AJPH.2017.303825","article-title":"Polysubstance use among US women of reproductive age who use opioids for nonmedical reasons.","volume":"107","author":"Jarlenski","year":"2017","journal-title":"Am J Public Health"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2019.02.030","article-title":"Age differences in emergency department utilization and repeat visits among patients with opioid use disorder at an urban safety-net hospital: a focus on young adults.","volume":"200","author":"Choi","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jsat.2014.04.006","article-title":"Emerging adult age status predicts poor buprenorphine treatment retention.","volume":"47","author":"Schuman-Olivier","year":"2014","journal-title":"J Subst Abuse Treat"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/ajad.12414","article-title":"Predictors of early dropout in outpatient buprenorphine\/naloxone treatment.","volume":"25","author":"Marcovitz","year":"2016","journal-title":"Am J Addict"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s11606-019-05405-9","article-title":"Differences in naloxone prescribing by patient age, ethnicity, and clinic location among patients at high-risk of opioid overdose.","volume":"35","author":"Kispert","year":"2020","journal-title":"J Gen Intern Med"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11606-019-05423-7","article-title":"Association of opioid overdose risk factors and naloxone prescribing in US adults.","volume":"35","author":"Lin","year":"2020","journal-title":"J Gen Intern Med"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11606-010-1253-9","article-title":"Primary medication non-adherence: analysis of 195,930 electronic prescriptions.","volume":"25","author":"Fischer","year":"2010","journal-title":"J Gen Intern Med"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"441","DOI":"10.7326\/M13-1705","article-title":"The incidence and determinants of primary nonadherence with prescribed medication in primary care: a cohort study.","volume":"160","author":"Tamblyn","year":"2014","journal-title":"Ann Intern Med"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"108346","DOI":"10.1016\/j.jsat.2021.108346","article-title":"Fill rate of naloxone prescriptions after video vs written opioid education programs.","volume":"127","author":"McElhinny","year":"2021","journal-title":"J Subst Abuse Treat"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"001","DOI":"10.17352\/2455-3484.000027","article-title":"Naloxone fill rates after opioid overdose.","volume":"5","author":"Ruff","year":"2019","journal-title":"J Addict Med Ther Sci"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ajem.2018.05.044","article-title":"Naloxone prescriptions from the emergency department: an initiative in evolution.","volume":"37","author":"Verdier","year":"2019","journal-title":"Am J Emerg Med"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.2019.7988","article-title":"Naloxone co-prescribing to patients receiving prescription opioids in the Medicare part D program, United States, 2016-2017.","volume":"322","author":"Jones","year":"2019","journal-title":"JAMA"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"e196215","DOI":"10.1001\/jamanetworkopen.2019.6215","article-title":"Association of naloxone coprescription laws with naloxone prescription dispensing in the United States.","volume":"2","author":"Sohn","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R33-20250502","first-page":"1135","article-title":"Boosting naloxone prescribing.","volume":"322","author":"Kuehn","year":"2019","journal-title":"JAMA"},{"key":"R34-20250502","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s40264-020-00923-6","article-title":"Rates and costs of dispensing naloxone to patients at high risk for opioid overdose in the United States, 2014-2018.","volume":"43","author":"Barenie","year":"2020","journal-title":"Drug Saf"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000005976","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:33:37Z","timestamp":1786113217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000005976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000005976","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,16]]}}}